Insulin Intensification for Hyperglycemia Management

Introduction to Insulin Intensification

The American Diabetes Association recommends considering insulin therapy when A1C is ≥10%, especially with marked hyperglycemia 1
Patients with high baseline A1C (≥9.0%) have a low probability of achieving glycemic targets with oral monotherapy or even dual oral therapy 2, 3
When A1C is ≥10-12%, insulin therapy should be strongly considered from the outset to rapidly correct hyperglycemia 4, 3

The current Lantus dose of 6 units is very low and likely subtherapeutic for a patient with this degree of hyperglycemia 4, 5
A common starting dose for basal insulin is 10 units or 0.1-0.2 units/kg/day, with gradual upward titration 5

Titrate Lantus upward from current 6 units using a self-titration algorithm based on fasting blood glucose values 5
Consider adding prandial insulin or GLP-1 receptor agonist if basal insulin titration alone doesn't achieve target 1, 5
For patients with A1C >10%, a basal-bolus insulin regimen may be necessary 5

Ensure proper education on glucose monitoring, insulin injection technique, insulin storage, and hypoglycemia recognition/treatment 4
Monitor closely for hypoglycemia with insulin intensification, especially with concurrent sulfonylurea use
Once symptoms are relieved and control is achieved, it may be possible to taper insulin partially and transfer to non-insulin agents 4, 3

Delaying insulin intensification with an A1C of 11% can lead to prolonged hyperglycemia and increased risk of complications 2, 3
Starting with too low a dose and failing to titrate appropriately is a common pitfall 5
Failing to properly educate the patient on insulin administration and hypoglycemia management can lead to poor adherence and outcomes 4
Continuing to emphasize diet and exercise remains important even when intensifying pharmacological therapy 2

The American Diabetes Association recommends increasing basal insulin by 2-4 units every 3-7 days based on fasting blood glucose values until target is achieved 6
When HbA1c is ≥1.5% above the individualized glycemic goal, many patients require more aggressive insulin titration or additional therapy 6

Increase glargine by 2-4 units every 3-7 days targeting fasting glucose of 80-130 mg/dL 6
Monitor fasting blood glucose daily during titration to guide dose adjustments 6
If basal insulin reaches 0.5 units/kg/day without achieving HbA1c goal, consider adding prandial insulin 6

Monitor for hypoglycemia, particularly if fasting glucose drops below 70 mg/dL, and reduce insulin dose by 10-20% if this occurs 6
Check HbA1c every 3 months to assess response to therapy 6, 7
Continue home blood glucose monitoring, particularly fasting values, to guide insulin titration 7

Premature addition of prandial insulin before optimizing basal insulin increases complexity, cost, and hypoglycemia risk without addressing the primary issue of inadequate basal coverage 6